wearable biosensor

By  Dave Muoio 02:24 pm July 14, 2020
Decentralized digital therapeutic trial. Pear Therapeutics has enrolled the first participant in the DREAM study, an open-label trial of its Somryst prescription digital therapeutic for chronic insomnia. Conducted as a decentralized trial, the effort will recruit U.S. adults aged 22 to 75 years who have an Insomnia Severity Index score of 8 or higher, as well as at least three months of insomnia...
By  Heather Mack 01:24 am May 23, 2017
San Jose, California-based VitalConnect, a maker of wearable sensors for remote monitoring, has raised $33 million in Series C financing in a round led by MVM Life Science Partners and Baxter International. The company, which last raised money in June 2016, plans to use the funding to move forward with commercializing its remote monitoring platform and medical-grade wearable sensor system. The...